Research Reports
Alpha Pro Tech (NYSE:APT)
Alpha Pro Tech, Ltd. is the parent company of Alpha Pro Tech, Inc. and Alpha ProTech Engineered Products, Inc. Alpha Pro Tech, Inc. develops, manufactures and markets innovative disposable and limited-use protective apparel products for the industrial, clean room, medical and dental markets. Alpha ProTech Engineered Products, Inc. manufactures and markets a line of construction weatherization products, including building wrap and roof underlayment. The Company has manufacturing facilities in Salt Lake City, Utah; Nogales, Arizona; Valdosta, Georgia; and a joint venture in India. For more information and copies of all news releases and financials, visit Alpha Pro Tech's Website at http://www.alphaprotech.com
Coverage Highlight: Ludlow Research Issues Opinion on APT Based on Increased Mandate for Face Masks as COVID-19 Cases Spike in Several US States
Price Target: $25.00
Updated: June 24, 2020 (pdf)
DownloadGTX Corp (OTC:GTXO)
GTX Corp (OTC: GTXO) is a pioneer in smart, mobile and wearable GPS tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. GTX offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications. GTX Corp utilizes the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC and BLE technology, enabling subscribers to track in real time the whereabouts of people or high value assets. GTX Corp’s business model is built around technology innovation and holds over 85 patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers in over 35 countries and is a U.S. Military Government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers. www.GTXCorp.com
Coverage Highlight: Ludlow Research Updates Opinion on GTXO Based on Renewed Outbreak of COVID-19 Cases in Western U.S.
Price Target: $0.05 to $0.08
Updated: June 12, 2020 (pdf)
DownloadRiot Blockchain (NASDAQ:RIOT)
Riot Blockchain (NASDAQ: RIOT) specializes in cryptocurrency mining with a focus on bitcoin. Riot also holds non-controlling investments in blockchain technology companies. Riot is headquartered in Castle Rock, Colorado, and the Company’s primary mining facility is located in Oklahoma City, Oklahoma. For more information, visit www.RiotBlockchain.com
Coverage Highlight: RIOT is positioned for upside interest as demand for bitcoin grows as an alternative investment to Gold and US Treasuries.
Short-term Target: $4.00 to $5.00
Updated: May 15, 2020 (pdf)
DownloadHammer Fiber (OTCQB:HMMR)
Hammer Fiber Optics Holdings Corp. (OTCQB:HMMR) is a telecommunications company investing in the future of wireless technology. Hammer’s “Everything Wireless” go to market strategy includes the development of high-speed fixed wireless service for residential and small businesses using its wireless fiber platform, Hammer Wireless® AIR, Over-the-Top services such as voice, SMS and video collaboration services, the construction of smart city networks and hosting services including cloud and colocation. www.hammerfiber.com
Target: $0.50+ (speculative)
Updated: Feb. 17, 2020 (pdf)
DownloadSinglePoint - Direct Solar (OTC:SING)
Direct Solar of America is a subsidiary of SinglePoint Inc. (OTCQB: SING). Direct Solar of America, a solar energy brokerage, helps find and install the best available solar energy system for any building, residential or commercial. https://directsolaramerica.com/
Target: $0.015 - $0.02
Updated: Feb. 12, 2020 (pdf)
DownloadAuris Medical Holding (EARS)
- Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental disorders supportive care. The company is focused on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). This program is currently in Phase 1. In addition Auris Medical has two Phase 3 programs under development: AM-111 for sudden sensorineural hearing loss and Keyzilen® (AM-101) for acute inner ear tinnitus.
Updated: Oct. 18, 2018 (pdf)
DownloadCopyright © 2006 - 2020 Ludlow Research - All Rights Reserved.